Giant Cell Tumor of Bone: Definition, Symptoms, Diagnosis, and Treatment
Definition of Giant Cell Tumor of Bone
Giant cell tumor of bone is a bone tumor that can show aggressive behavior, appearing as a result of uncontrolled and abnormal proliferation of osteoclastic giant cells—that is, the cells responsible for bone breakdown. While these cells normally take part in the bone-renewal process, in giant cell tumor of bone this mechanism is disrupted and bone tissue begins to be destroyed rapidly. The tumor therefore weakens the bone in the area where it is found, empties it, and makes it fragile.
Giant cell tumor of bone is seen most in young and middle-aged adults between 20 and 40 years of age and is encountered a little more often in women than in men. Active bone metabolism in this age group is accepted as an important factor for the development of the tumor. Although a large share of these tumors is classified as benign, they can behave very aggressively locally and rapidly destroy surrounding healthy bone tissue. In rare cases they can show malignant transformation or metastasize to distant organs such as the lung.
Giant cell tumors of bone can usually reach sizes varying between 3 and 10 cm and continue to grow over time if untreated. As the tumor grows, bone integrity is disrupted, joint surfaces can be harmed, and this increases the patient’s risk of severe pain, limited motion, and pathologic fracture. When it sits in load-bearing joint regions such as around the knee, the wrist, the hip, and the shoulder, the patient’s daily quality of life is seriously affected.
Because of these features, giant cell tumor of bone, although most often accepted as benign, is an important orthopedic oncology disease that can behave aggressively enough to be confused with bone cancer and that definitely requires specialist assessment. Early diagnosis and appropriate treatment planning are of vital importance for protecting the bone and preventing loss of function.

Symptoms
Giant cell tumor of bone shows itself with slowly progressing but steadily more severe symptoms, depending on the bone and joint region where it is found. As the tumor grows, it weakens the structure of the bone and puts pressure on surrounding soft tissues. A large share of patients therefore see a doctor with complaints that are mild at the beginning but increase over time. The most common symptoms are:
Pain: The most common symptom of giant cell tumor of bone is pain. This pain may be mild and intermittent at the beginning, but as the tumor grows it becomes continuous and severe. Pain that increases especially at night and does not go away with rest is an important sign that the tumor is progressing inside the bone. When it sits in load-bearing bones, pain is more obvious while walking or moving.
Swelling and a sense of a mass: When the tumor expands the bone outward, visible or palpable swelling can form in the affected area. This swelling hardens over time and can be noticed as a mass under the skin. This symptom is common especially in giant cell tumors of bone around the knee, wrist, or shoulder.
Limited motion: When the tumor sits near a joint, the joint’s normal movement is disrupted. This shows itself with joint stiffness and difficulty bending and straightening. Patients may feel pain and strain when climbing stairs, sitting and standing, or lifting the arm.
Pathologic fracture risk: Because giant cell tumor of bone weakens the inner structure of the bone, even a small blow or a simple movement can lead to bone fracture. These fractures are called pathologic fractures and can often be the first reason the disease is noticed.
Increased warmth and tenderness: In some patients, local increased warmth and tenderness to touch can develop in the area where the tumor is found. This can show that the tumor is growing actively and aggressively.
These symptoms become more severe as giant cell tumor of bone progresses and can seriously reduce the patient’s quality of life. Seeing an orthopedic oncology specialist is therefore of great importance especially in cases of persistent bone pain, swelling, or sudden fracture.
Diagnostic Methods for Giant Cell Tumor of Bone
Correct identification of giant cell tumor of bone is extremely critical for planning appropriate treatment. Although this tumor shows typical features with some imaging findings, because it can be confused with benign and malignant bone tumors, the diagnostic process must be conducted in a systematic, multifaceted way. Clinical assessment, imaging methods, and pathologic examination are used together in the diagnostic process.
1. Physical Examination
The first step of the diagnostic process is physical examination. The orthopedics and orthopedic oncology specialist assesses findings such as the presence of swelling or a mass in the affected area, the level of tenderness and pain, limited motion, and the status of joint functions. A detailed history is also taken, such as when the pain started, whether it has steadily increased, whether there is night pain, and whether the patient has had trauma before. This information provides important clues in distinguishing giant cell tumor of bone from other bone lesions.
2. Imaging Methods
X-ray: This is the first and most basic stage of diagnosis. Giant cell tumor of bone is usually seen on X-ray images as a lesion close to the end of the bone (epiphysis–metaphysis region), thinning the bone cortex, lytic (bone-eroding), and showing balloon-like expansion. This characteristic appearance allows a preliminary diagnosis of the disease to be made.
Magnetic Resonance Imaging (MRI): MRI is very important in assessing spread of giant cell tumor of bone into soft tissues, whether it extends into the joint, and its relationship with surrounding muscle, nerve, and vessel structures. Bleeding inside the tumor, fluid areas, and findings of aggressive growth can also be seen in detail with MRI.
Computed Tomography (CT): CT is used especially to assess the cortical structure of the bone and how much the tumor has weakened the bone. Before surgical planning, it provides a great advantage in clearly determining the tumor’s boundaries inside the bone.
3. Biopsy
In giant cell tumor of bone, definite diagnosis is made with biopsy. Even if imaging methods create a strong suspicion, examination of samples taken from the tumor under a microscope is mandatory. Biopsy can be done with the following methods: fine-needle biopsy, core (tru-cut) biopsy, or open surgical biopsy. In pathologic examination, the density of osteoclast-like giant cells and the structure of the tumor cells are assessed. With this examination it is determined clearly whether the tumor is benign or has shown malignant transformation.
Treatment Options for Giant Cell Tumor of Bone
Treatment of giant cell tumor of bone is planned according to the size of the tumor, which region of the bone it is in, joint involvement, the patient’s age, and general health. The aim is not only to eliminate the tumor, but also to protect bone function and the patient’s quality of life. The treatment process is therefore usually managed by orthopedic oncology specialists.
1. Surgical Treatment
In giant cell tumors of bone, the gold-standard treatment is surgery. Different surgical techniques can be applied according to the region where the tumor is found.
Curettage and Local Treatment: This is the most frequently applied method in early-stage and limited tumors. Tumor tissue is scraped out from inside the bone; then local adjuvants such as phenol, alcohol, liquid nitrogen, or a high-speed burr are used to destroy remaining microscopic tumor cells. The resulting cavity is filled with bone cement or bone graft. This method provides a great advantage in protecting joint function especially in tumors sitting near a joint.
Wide Resection and Reconstruction: If the tumor is very large, has seriously weakened the bone, or has spread into soft tissues, more aggressive surgery may be needed. The tumor is removed together with surrounding healthy bone tissue, and the resulting bone loss is repaired with a prosthesis, metal implants, or bone graft. This approach reduces recurrence risk, but the rehabilitation process after surgery may be longer.
2. Drug Treatment (Denosumab and Targeted Therapies)
In recent years, the targeted drug denosumab has played an important role in the treatment of giant cell tumor of bone. This drug suppresses osteoclast activity, provides shrinkage of the tumor, and can make surgery easier and safer. Denosumab is used as a very effective supportive treatment especially in regions where surgery is difficult (spine, pelvis), in large and aggressive tumors, and in recurrent cases.
3. Radiotherapy
Giant cell tumors of bone are usually treated with surgery. For cases that cannot be completely removed surgically, that sit in risky regions such as the spine or skull, or that recur, however, radiotherapy can be an important alternative. Radiotherapy brings growth under control by suppressing proliferation of tumor cells. Thanks to modern radiation techniques today, harm to surrounding tissues is minimized.
4. Chemotherapy
Most giant cell tumors of bone do not respond well to chemotherapy. If malignant transformation has rarely developed, or if lung metastasis has formed, however, chemotherapy can be added to the treatment plan. This decision is made by a multidisciplinary board.
5. Follow-Up and Recurrence Risk
In giant cell tumors of bone, the risk of recurrence is high. Regular follow-up should therefore be done with X-ray, MRI, or CT every 3–6 months in the first 2 years after treatment, and at least once a year in later years. Because lung metastasis can rarely be seen, lung CT is also added to the monitoring program in some patients.
Conclusion
Giant cell tumor of bone, although most often classified as benign, is an aggressive bone tumor that can seriously weaken bone structure, disrupt joint functions, and has a high risk of recurrence. When it sits in functionally critical regions such as around the knee, the hip, the shoulder, and the wrist, early diagnosis and correct treatment are of vital importance.
Today, extremely successful results are obtained in the treatment of giant cell tumor of bone by using surgery, targeted drugs (especially denosumab), and radiotherapy when needed together. The most important factor, however, is that the patient’s diagnostic and treatment process is conducted in an orthopedic oncology center experienced in bone tumors.
Prof. Dr. Yavuz Arıkan, who stands out in Turkey in the field of bone and soft-tissue tumors, offers a multidisciplinary approach in the diagnosis and treatment of all benign and malignant bone tumors, including giant cell tumor of bone. Thanks to advanced imaging methods, correct biopsy techniques, and modern surgical applications, patients can reach both a correct diagnosis and an individualized treatment plan.
Cases of giant cell tumor of bone that are delayed or incorrectly treated can lead to fracture, joint loss, or recurrent tumors. Patients who experience suspicious bone pain, swelling, or limited motion should therefore see specialist centers without delay, which is of critical importance for long-term success and quality of life.
Frequently Asked Questions
Frequently Asked Questions
Giant cell tumor of bone is most often classified as benign; however, it has the potential to grow aggressively, destroy surrounding bone, and rarely transform into a malignant tumor. It should therefore not be seen as a simple mass and should be assessed by orthopedic oncology specialists.
It is seen most around the knee (lower end of the femur and upper end of the tibia), the wrist, the shoulder, and the hip bones. Because it sits near a joint, it often causes limited motion and pain.
Yes. The risk of recurrence after surgery is between 10% and 30%. Patients should therefore be followed regularly after surgery with MRI and X-ray. Wide resection and modern surgical techniques applied by Prof. Dr. Yavuz Arıkan in Istanbul significantly reduce recurrence risk.
Diagnosis is made with X-ray, MRI, CT, and always biopsy. A definite diagnosis cannot be made with imaging alone. Incorrectly performed biopsies can lead to spread of the tumor, so the procedure must be done in centers specialized in bone tumors.
Yes. Because giant cell tumor of bone weakens the bone, the risk of pathologic fracture is high. Tumors around the knee and hip in particular can prevent the patient from walking.
Denosumab is a targeted drug used in giant cell tumors of bone. It shrinks the tumor by suppressing osteoclast activity and makes surgery safer. It is used effectively by Prof. Dr. Yavuz Arıkan before or after surgery in suitable patients.
In some cases a second operation may be needed if recurrence develops. Long-term follow-up is therefore very important. Patients are usually placed in a regular monitoring program for 5–10 years.
In rare cases it can metastasize to the lung or transform into a malignant tumor. This tumor should therefore not be seen as a simple ‘benign mass’ and should be managed by an orthopedic oncology specialist.
Led by Prof. Dr. Yavuz Arıkan, who is specialized in bone tumors, international-standard care is provided in the diagnosis and treatment of all bone and soft-tissue tumors, including giant cell tumor of bone.